Long Covid Analysed
Long Covid Analysed Podcast
Guanfacine and the potential cognitive impact in long Covid therapy
6
1×
0:00
-5:09

Guanfacine and the potential cognitive impact in long Covid therapy

Dr Philip McMillan
Feb 15, 2023
6
Share

Recently discussing about the mechanism of action of this drug and how it helps to clarify primary pathophysiology in long Covid.

Potential New Treatment for “Brain Fog” in Long COVID Patients >

Arnsten, Amy FT, and Lu E. Jin. "Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale." The Yale journal of biology and medicine 85.1 (2012): 45.

The most important question is not just what works, but why it has an impact.

Thanks for reading Long Covid Analysed! Subscribe for free to receive new posts and support my work.

6 Comments
Long Covid Analysed
Long Covid Analysed Podcast
Thorough investigation into all aspects of long Covid disease
Listen on
Substack App
RSS Feed
Appears in episode
Dr Philip McMillan
Recent Episodes
The first step to better health starts here
 • Dr Philip McMillan
IL-10: Key Factor in MECFS and Long Covid
 • Dr Philip McMillan
Which Cytokine is Dysfunctional in Long Covid?
 • Dr Philip McMillan
Prior Subclinical Inflammation Predisposes to Long Covid
 • Dr Philip McMillan
Could a Ketogenic Diet help with Long Covid Fatigue?
 • Dr Philip McMillan
Is Long Covid a Real Disease?
 • Dr Philip McMillan
Long Anaemia of Long Covid
 • Dr Philip McMillan
PET Scan and Epipharyngeal Inflammation.
 • Dr Philip McMillan